Aspergillosis Therapy
New findings from Tenon Hospital in the area of aspergillosis therapy described
Published in TB and Outbreaks Week, June 12th, 2007
Data detailed in "Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients" have been presented. "There is no recognized medical treatment for chronic pulmonary aspergillosis (CPA) apart from surgery in patients with simple aspergilloma. To evaluate the efficacy of voriconazole in this setting, we conducted a retrospective multicenter study over a 3-year period," researchers in Paris, France report.
"For inclusion in the study, patients had to have received voriconazole for treatment of confirmed or probable CPA with a follow-up of at least 6 months. Clinical, radiologic, and mycologic data were collected at baseline, every 2 to 3...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Bird Flu
Human antibodies protect mice from avian flu - Bird Flu
Veterinarians At Increased Risk Of Avian Influenza Virus Infection - Flu Vaccines
FDA Finalizes Guidances for Pandemic and Seasonal Influenza Vaccines - Bird Flu
Hemispherx Presents Potential Avian Influenza Treatment Breakthrough at Paris Conference - Bird Flu
New Images Show Virus Dismantled by Broad-Spectrum NanoViricides - Bird Flu
OneWorld Health Featured in BBC World Documentary - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
